BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2817784)

  • 1. Long-term results with FAMTX (5-fluorouracil, adriamycin, methotrexate) in advanced gastric cancer.
    Klein HO
    Anticancer Res; 1989; 9(4):1025-6. PubMed ID: 2817784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose MTX/5-FU and adriamycin for gastric cancer.
    Klein HO; Wickramanayake PD; Dieterle F; Mohr R; Oerkermann H; Gross R
    Semin Oncol; 1983 Jun; 10(2 Suppl 2):29-31. PubMed ID: 6603023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sequential methotrexate and 5-fluorouracil].
    Sasaki T
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1907-10. PubMed ID: 8978795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biochemical modulation with sequential methotrexate (MTX)-5-fluorouracil (5-FU) treatment].
    Ota K; Murakami M
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1642-9. PubMed ID: 3496047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of sequential methotrexate and 5-fluorouracil chemotherapy in previously treated gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group, JCOG 9207 trial.
    Hamaguchi T; Shirao K; Yamamichi N; Hyodo I; Koizumi W; Seki S; Imamura T; Honma H; Ohtsu A; Boku N; Mukai T; Yamamoto S; Fukuda H; Yoshida S;
    Jpn J Clin Oncol; 2008 Jun; 38(6):432-7. PubMed ID: 18515821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sequential methotrexate-5-fluorouracil (MTX-5-FU) treatment of patients with advanced gastric and colorectal cancer. Sequential Methotrexate-5-FU Study Group].
    Murakami M; Ota K; Miyazaki T; Niitsu Y; Wakui A; Yokoyama M; Kanamaru R; Futatsuki K; Akazawa S; Sakai Y
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2482-90. PubMed ID: 3619460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sequential chemotherapy with methotrexate and 5-fluorouracil for advanced gastric cancer].
    Iwamoto S; Kimoto M; Mure T; Onuma E; Yamamoto Y; Iki K; Yoshida K; Tadaoka Y; Majima T; Kawasaki S; Kubozoe T; Tsunoda T
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):541-6. PubMed ID: 9530360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
    Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
    Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of sequential MTX/5-FU therapy for gastric cancer].
    Hiraishi M; Konishi T; Makuuchi M
    Gan To Kagaku Ryoho; 1995 Jul; 22(8):994-1000. PubMed ID: 7611769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial.
    Yamao T; Shimada Y; Shirao K; Ohtsu A; Ikeda N; Hyodo I; Saito H; Iwase H; Tsuji Y; Tamura T; Yamamoto S; Yoshida S
    Jpn J Clin Oncol; 2004 Jun; 34(6):316-22. PubMed ID: 15333683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinoma.
    Mikhak B; Zahurak M; Abeloff MD; Fetting JH; Davidson NE; Donehower RC; Waterfield W; Kennedy MJ
    Cancer; 1999 Feb; 85(4):899-904. PubMed ID: 10091768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low-dose methotrexate and sequential 5-FU treatment in advanced gastric cancer].
    Sasaki T; Ibuka T; Imai K; Sakai Y; Ishiwata J; Satomi T
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2408-13. PubMed ID: 6497399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, measurable adenocarcinoma of the lung and stomach.
    Cazap EL; Gisselbrecht C; Smith FP; Estevez RA; Alvarez CA; Lagarde C; Hannois A; Ahmed S; Schein PS; Woolley PV
    Cancer Treat Rep; 1986 Jun; 70(6):781-3. PubMed ID: 3524826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I trial of a modified, dose intensive FAMTX regimen (high dose 5-fluorouracil+doxorubicin+high dose methotrexate+leucovorin) with oral uridine rescue.
    Schwartz GK; Christman K; Saltz L; Casper E; Quan V; Bertino J; Martin DS; Colofiore J; Kelsen D
    Cancer; 1996 Nov; 78(9):1988-95. PubMed ID: 8909321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination chemotherapy of CPM-MTX-5-FU in non-resectable and recurrent cancer patients].
    Saeki T; Jinushi K; Kim R; Toi M; Saeki K; Yoshinaka K; Yanagawa E; Niimoto M; Hattori T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):827-31. PubMed ID: 2712579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer.
    Bokemeyer C; Hartmann JT; Lampe CS; Clemens MR; Quietzsch D; Forkmann L; Kanz L
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-96-S19-100. PubMed ID: 9427277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of sequential methotrexate and 5-fluorouracil in metastatic pancreatic cancer.
    Ikeda M; Okada S; Ueno H; Okusaka T; Tanaka N; Kuriyama H; Yoshimori M
    Hepatogastroenterology; 2000; 47(33):862-5. PubMed ID: 10919048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer.
    Oh SY; Kwon HC; Seo BG; Kim SH; Kim JS; Kim HJ
    Acta Oncol; 2007; 46(3):336-41. PubMed ID: 17450469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.